The introduction of biological agents such as anti-tumor necrosis factor (TNF)-α, has had a profound effect on the management of rheumatic arthritis, including both rheumatoid arthritis (RA) and ankylosing spondylitis (AS) [1, 2]. Here, TNF is linked to rheumatoid arthritis.